E-LIB Suche - Ergebnisse für: Robert C. Moellering

1

Whole Genome Characterization of the Mechanisms of Daptomyc..:

Peleg, Anton Y. ; Miyakis, Spiros ; Ward, Doyle V....
PLoS ONE. 7 (2012) 1 - p. e28316 , 2012

2

Reply to Lalueza et al:

Peleg, Anton Y. ; Pillai, Satish ; Mylonakis, Eleftherios..
The Journal of Infectious Diseases. 201 (2010) 2 - p. 312-313 , 2010

Link: https://doi.org/10.1086/..

3

Development of Reduced Vancomycin Susceptibility in Methici..:

Pillai, Satish K. ; Wennersten, Christine ; Venkataraman, Lata...
Clinical Infectious Diseases. 49 (2009) 8 - p. 1169-1174 , 2009

Link: https://doi.org/10.1086/..

4

The Rationale for Revising the Clinical and Laboratory Stan..:

Tenover, Fred C. ; Robert C. Moellering, Jr.
Clinical Infectious Diseases. 44 (2007) 9 - p. 1208-1215 , 2007

Link: https://www.jstor.org/st..

5

Genetic Diversity among Enterococcus faecalis:

McBride, Shonna M. ; Fischetti, Vincent A. ; LeBlanc, Donald J....
PLoS ONE. 2 (2007) 7 - p. e582 , 2007

Link: https://doi.org/10.1371/..

6

Adaptation of Methicillin-Resistant Staphylococcus aureus i..:

George Sakoulas ; Robert C. Moellering, Jr. ; George M. Eliopoulos
Clinical Infectious Diseases. 42 (2006) - p. S40-S50 , 2006

Link: https://www.jstor.org/st..

7

Effects of prolonged vancomycin administration on methicill..:

Sakoulas, George ; Gold, Howard S. ; Cohen, Robert A....
Journal of Antimicrobial Chemotherapy. 57 (2006) 4 - p. 699-704 , 2006

Link: https://doi.org/10.1093/..

8

The Importance of Bactericidal Drugs: Future Directions in ..:

Finberg, Robert W. ; Robert C. Moellering ; Tally, Francis P....
Clinical Infectious Diseases. 39 (2004) 9 - p. 1314-1320 , 2004

Link: https://www.jstor.org/st..

9

Accessory Gene Regulator Group II Polymorphism in Methicill..:

Pamela A. Moise-Broder ; George Sakoulas ; George M. Eliopoulos...
Clinical Infectious Diseases. 38 (2004) 12 - p. 1700-1705 , 2004

Link: https://www.jstor.org/st..

10

The United States Food and Drug Administration and the End ..:

David M. Shlaes ; Robert C. Moellering, Jr.
Clinical Infectious Diseases. 34 (2002) 3 - p. 420-422 , 2002

Link: https://www.jstor.org/st..

11

The Continuing Challenge of Lower Respiratory Tract Infecti..:

Robert C. Moellering, Jr.
Clinical Infectious Diseases. 34 (2002) - p. S1-S3 , 2002

Link: https://www.jstor.org/st..

12

General Discussion:

Zinner, Stephen H. ; Richard Wise ; Robert C. Moellering, Jr.
Clinical Infectious Diseases. 33 (2001) - p. S251-S260 , 2001

Link: https://www.jstor.org/st..

13

Editorial Response: Staphylococci vs. Glycopeptides: How Mu..:

Robert C. Moellering, Jr.
Clinical Infectious Diseases. 29 (1999) 4 - p. 768-770 , 1999

Link: https://www.jstor.org/st..

14

Quinupristin/dalfopristin: therapeutic potential for vancom..:

Moellering, Robert C.
Journal of Antimicrobial Chemotherapy. 44 (1999) suppl_1 - p. 25-30 , 1999

Link: https://doi.org/10.1093/..

15

Vancomycin-Resistant Enterococci:

Robert C. Moellering, Jr.
Clinical Infectious Diseases. 26 (1998) 5 - p. 1196-1199 , 1998

Link: https://www.jstor.org/st..